APA (7th ed.) Citation

M, G., JS, Y., S, C. Q., M, K., J, d. G., & H, O. (2025). Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations. Neuro-oncology, 27(2), 352. https://doi.org/10.1093/neuonc/noae203

Chicago Style (17th ed.) Citation

M, Gallus, Young JS, Cook Quackenbush S, Khasraw M, de Groot J, and Okada H. "Chimeric Antigen Receptor T-cell Therapy in Patients with Malignant Glioma-From Neuroimmunology to Clinical Trial Design Considerations." Neuro-oncology 27, no. 2 (2025): 352. https://doi.org/10.1093/neuonc/noae203.

MLA (9th ed.) Citation

M, Gallus, et al. "Chimeric Antigen Receptor T-cell Therapy in Patients with Malignant Glioma-From Neuroimmunology to Clinical Trial Design Considerations." Neuro-oncology, vol. 27, no. 2, 2025, p. 352, https://doi.org/10.1093/neuonc/noae203.